Tag | Content |
---|
EnhancerAtlas ID | HS092-08923 |
Organism | Homo sapiens |
Tissue/cell | HFF |
Coordinate | chr11:33933130-33934860 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
LBX2 | MA0699.1 | chr11:33934227-33934237 | GCTAATTGGC | - | 6.02 | MEOX1 | MA0661.1 | chr11:33934195-33934205 | GCTAATTAAC | + | 6.02 | ZNF263 | MA0528.1 | chr11:33934123-33934144 | TTCTCTTCCCCTGGCTCCTCT | - | 6.07 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09380 | chr11:33931760-33936195 | CD14 | SE_13375 | chr11:33932922-33934965 | CD34_Primary_RO01536 | SE_14120 | chr11:33933145-33934586 | CD34_Primary_RO01549 | SE_33500 | chr11:33930714-33936676 | H2171 | SE_68369 | chr11:33920144-33976413 | TC32 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr11 | 33933768 | 33934799 | chr11 | 33933945 | 33934087 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I033912 | chr11 | 33933713 | 33934903 |
|
Enhancer Sequence | CCTGGCCTTA ATTTCCTGGC TTTTGTTAAA AAAAAAGAAA AGAAAAGAAA AGAAACTTCT 60 ATCTTGTCTA AGCCACTGCT TTGGAGGAGT TTCTGTCACT TGTATTTGAA CCCAGTCTTA 120 ATTGGTACAA CAGCTTTTGT CAATGGTAAA GAAGTGGAAA CAACCTTAGT GGCCCACAAG 180 AAAGGACTGG CTAAATTCGT TCACTCATTT ACTTACTCAT TTATCGCATT TTTAATGAGT 240 GCCCACCACA TGCTCGGCTT TGATCTAGGC TCTGAGCTAT GGGGGATATA GTGGTAAAAA 300 GGTATTGTCT CTACCCTGAA GAACTTTGTT AGAAGAGGAG GCAGAAGGCA TAAGTAAATG 360 CGCAATACAA TGATGTGTAA TTAGCGGAAC CACAGAGGCT AAGTAGTTAA AAAAACATTT 420 TAAAACAGGA TAGGAAAAAT GGTGACGCAT TGCTAAAAAG GGGATAATTA AAGATCATGC 480 ACAGTGAGTT CAATTTGTAA AACAGCATAT ATATTTGCAT GGAGAAAAAA CTAAACTGAT 540 ATATGCTTTT TCTGAACACC TTGAACAGCA GTGGTATTTA GTAGGTAAAC AATAAATGAT 600 TAATGAATGA AAGAATCTAT TTCAAGATCA AGGGATTATT TTTTCTAGGT ATTTTTCTGT 660 ACTTTCCAAA TGCCGCCCAA TAAGTATGTA TTACTTTTGT AATAAGGAAA AAATATCAAC 720 ATTAGGAAAC TGTGAATTAG GGAGTTAAGG ATCAAGATGA CGTGTAGAGC AGCGATTTTT 780 GTTAGAATGC AAACTAAGCT GTGCTAGACT TAGTCTCAAA AAGAAATGTA AGTCTGAGGT 840 CTGAGTTTGG CCTCTCCCTA ACGGGCGGAG ACTGTGGCTC TCCACCCCAT GCACGGTCCG 900 GAAGCAGGCA AGCAAGTTTG CCCTGGGCTT TGTTCTACAT TTTAGTGGGG CAGGGCCCAC 960 TGCAGCCAAG TTATTAAGCA CTAGGTCTCT CACTTCTCTT CCCCTGGCTC CTCTCTGCTG 1020 GGCCTCCTGC CCTACCATCA AGGCAGCTGT TGTTGTTTTG TAGAGGCTAA TTAACTCCAC 1080 ACTGCATGAA GCCAGACGCT AATTGGCCCA CTCACTTAAT CAACCTTAAT GTCTCTCTTC 1140 TGGTGGACAC GGCTGCTGCT TTTTGTTCCC CTGATCATCA ACAAACGTGG TTCCAGGCGA 1200 ATGGCAGCAA CAGCCTCTGG TGGTAACAGC CCTCAGCCTG TCACCTACCA CGGGAAATAC 1260 TGAGGCTCAT TTTGACACCT CAGCTCAGTG GACAGGCCCT CAAGTTCATG ATCACCGAAG 1320 CATCTTGAAA CCTGAGCTTA TTGCTGCTCT TCCAAACATT GCATGATGAT ATGAGTCATC 1380 AGATGGTTGG TTACTCAAGA GAATTGGCCT CATCTCTGTC TGTTGCTGAC ACATAGTTAA 1440 GACTATAACA TCTAACTTAT ACAGCTACCT TTTGCTGAGT GTTTTTTTTT TTTCTGTAGC 1500 ACTGTGTCGG GGCCTTTCCA ATGGAACATG AACACAACAT TGCACAGAGT AGGTAAGCAA 1560 TACAGATTTT TAACCGAATG AGGAAGAAAC ACCATTCTTA TCCCATTTGT CAGATGAGGA 1620 CACTGAGGCA ACAATAATGT TTACATCTGT AATTGAAATG ATGTACATAT TCCTATAAGA 1680 TTAGGACCAA GAAGTATTCT AATCCCCCCA ACCTTTTTTT TTTTTTTTTT 1730
|